May 28, 2001 |
Even as prescription-only nasal treatments are helping many allergy sufferers manage their reaction to pollen, a new generation of medications is in the regulatory pipeline, awaiting the U.S. Food and Drug Administration's scrutiny. Pollen, which contains semen spores, is what plants use to mate. But humans get in the way. The histamine released from mast cells, which line the skin and mucous membranes, causes the symptoms, which are specific to where the pollen lands.
December 2, 2009
Each time a proposal comes along that would diminish our privacy to further a social good, society's job is to ask whether that good outweighs another stricture on our lives. A proposed state database to track our purchases of various cold and allergy remedies is designed to cut down on illegal methamphetamine manufacture -- a well-intentioned attempt to fight back at a drug that has become a law enforcement nightmare. But this legislation is unlikely to achieve enough benefits to make its downsides worthwhile.
July 31, 2005 |
The state Senate has approved a plan to make Oregon the first state in the nation to require a prescription for many cold and allergy medicines, an attempt by lawmakers to shut down methamphetamine labs. The Senate voted 26-4 to approve the measure, which now returns to the House. Gov. Ted Kulongoski supports it.
August 2, 2005 |
Lawmakers took their final step Monday toward making Oregon the first state to require a doctor's prescription for many cold and allergy medicines as part of an effort to shut down methamphetamine labs. The House voted 57 to 2 to send the bill to Democratic Gov. Ted Kulongoski, who is expected to sign it into law this week. He has called the measure a major step in the fight against rampant methamphetamine use.
June 29, 2004 |
The Supreme Court agreed Monday to consider the standard for proving securities fraud, in a case involving a maker of asthma and allergy medicines. The stock of Dura Pharmaceuticals Inc., a unit of Ireland's Elan Corp., plummeted 47% in one day after the company announced in February 1998 that it expected lower revenue because of slower-than-expected sales of the antibiotic Ceclor CD.
September 4, 2003 |
The Internal Revenue Service said Wednesday that the cost of nonprescription medicines qualified for reimbursement from flexible spending accounts and other pretax health-care plans. IRS officials said the announcement in part reflects the increasing number of onetime prescription drugs that are now sold over the counter. While such a shift typically lowers the price of a drug, it may increase out-of-pocket costs because insurance no longer pays for it.